Literature DB >> 3301078

Central effect of captopril on baroreflex.

K Takeda, H Okajima, J Hayashi, S Kawasaki, M Oguro, Y Nakamura, A Inoue, S Sasaki, M Nakagawa, H Ijichi.   

Abstract

To clarify effect of converting enzyme inhibitors (CEI) on heart rate regulation, captopril (2 mg/kg) was injected intravenously (i.v.) with or without pretreatment of atropine and also responses to intracisternal (i.c.) injections were examined. Captopril induced bradycardia with lowering blood pressure, and this bradycardia was abolished by pretreatment of atropine. Reduction of heart rate by i.c. injection of captopril was significantly larger than those of i.v. injection. Furthermore, to determine whether CEI can modify baroreflexes centrally, the aortic depressor nerve (ADN) was stimulated electrically in captopril treated rats. Vasodepressor and sympatho-inhibitory responses induced by ADN stimulation were significantly attenuated by captopril, while the bradycardiac response was not changed. These findings suggest that captopril attenuated centrally vasodepressor and sympatho-inhibitory responses of the baroreflex and activated centrally cardiac vagal efferent activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301078     DOI: 10.3109/10641968709164192

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  2 in total

1.  Sustained Captopril-Induced Reduction in Blood Pressure Is Associated With Alterations in Gut-Brain Axis in the Spontaneously Hypertensive Rat.

Authors:  Tao Yang; Victor Aquino; Gilberto O Lobaton; Hongbao Li; Luis Colon-Perez; Ruby Goel; Yanfei Qi; Jasenka Zubcevic; Marcelo Febo; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

2.  Haemodynamic Responses to Selective Vagal Nerve Stimulation under Enalapril Medication in Rats.

Authors:  Mortimer Gierthmuehlen; Thomas Stieglitz; Josef Zentner; Dennis T T Plachta
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.